Overview
PNC‑27 is a 32‑residue chimeric peptide derived from a segment of the p53 tumor‑suppressor protein. It is widely utilized in in vitro and laboratory‑based research involving protein–protein interactions, membrane‑binding mechanisms, and peptide‑induced pore‑formation pathways. PNC‑27 is of particular interest for studies examining its affinity for HDM‑2 (MDM2), a regulatory protein associated with cellular stress‑response pathways.
Molecular Characteristics
Peptide Type: p53‑derived chimeric peptide analog
Form: Lyophilized powder
Purity: ≥ 98% (HPLC)
Storage: –20°C recommended
Research Applications
PNC‑27 is commonly investigated in controlled laboratory environments for:
HDM‑2 binding studies
Peptide–membrane interaction analysis
Assay development involving pore‑formation mechanisms
In vitro modeling of cellular stress‑response pathways
Biochemical exploration of peptide‑induced membrane disruption
(All framed as research domains, not biological outcomes.)
Mechanistic Notes (Research Context Only)
In laboratory settings, PNC‑27 is studied for its interaction with:
HDM‑2 (MDM2) protein structures
Peptide‑mediated membrane insertion mechanisms
Pore‑formation pathways and membrane‑integrity models
These statements describe mechanistic interest, not biological effects in humans or animals.
Storage & Handling
Store lyophilized peptide at –20°C
Avoid repeated freeze–thaw cycles
Handle reconstituted solutions according to laboratory best practices
Important Research Notice
For laboratory research use only
Not for human consumption
Not a drug, food, or cosmetic
Not for veterinary or household use
No medical or therapeutic claims are made